Recent developments in the U.S. vaccine policy, particularly concerning the hepatitis B vaccine for newborns, have raised significant concerns among health experts and parents. A CDC advisory panel has voted to end the universal recommendation for administering the hepatitis B vaccine at birth, a decision being criticized by many as potentially harmful to public health. The panel, influenced by changes initiated by officials linked to RFK Jr., plans to review and potentially delay various childhood vaccination schedules. Critics argue that these changes could lead to a resurgence of hepatitis B infections and jeopardize the health of children. Experts emphasize the importance of the hepatitis B vaccine, which has been credited as life-saving, particularly for vulnerable populations. Discussions continue as the CDC faces backlash over its decisions, with many advocating for maintaining the previous guidelines to ensure protection against preventable diseases.